Celerion - HelpResearch - Tomorrow: Our Covid 19 Response
Questions? Call 1-866-445-7033 (US) or 02890 554000 (UK)
Participating in a clinical study at Celerion generally requires one or more overnight stays at our clinic and may include return visits or at-home dosing. The length of each stay and number of return visits is dependent on the needs of each study. At Celerion's clinic, participants are dosed with the study medication, may have multiple blood draws, vital sign measurements, and be monitored by on-site medical staff. During free time, participants may watch movies, play games, study, read or spend time on the internet, etc.
Celerion offers a variety of study opportunities. The majority of studies require overnight stays in a Celerion clinic however some studies are offered without overnight confinement. The different types of studies include:
Please go to Find a Clinical Study for more information.
A listing of all current studies can be found on the Find a Clinical Study page. Celerion also has Facebook and Twitter accounts that can be followed for all study opportunities. Otherwise, feel free to contact us by giving us a call.
Belfast: 02890 554000Lincoln: +1-402-476-2811Phoenix: +1-602-437-0097
The type of studies Celerion conducts generally require healthy participants, therefore we are not looking for individuals with specific medical conditions. The research Celerion conducts is not intended to determine the effectiveness of a medication. Our studies are run to determine how a medicine impacts the body.
Celerion conducts some studies that require participants with medical conditions such as type II diabetes or asthma. To learn more about whether we are currently recruiting any patient population studies please visit Find a Clinical Study.
A participant is only allowed to enroll in one study at a time. Following completion of each study there is a minimum waiting period before a participant can take part in another study. The waiting period is typically 30 days (but can be 90 days) and is referred to as the "pharmaceutical wash-out" period.
Each study has a specific set of qualifications that need to be met in order for a participant to take part in a particular study. Here are some general participant qualifications:
Regulatory agencies such as the Food and Drug Administration (FDA) or Medical Healthcare and Products Regulatory Agency (MHRA) require prescription and over-the-counter medication to be thoroughly tested. Celerion conducts clinical research on behalf of pharmaceutical and biotechnology companies to help determine the safety and efficacy while evaluating any potential side effects of taking the medication. This ensures that these products meet established quality standards and that the public's wellbeing is protected.
The potential risks will differ in each study. During the informed consent (ICF) process at screening any potential risks of participation will be reviewed and communicated before the ICF is signed. Some risks are unknown. Medical staff is available to address any questions or concerns that participants may have.
Each study will have certain restrictions that need to be followed to ensure accurate study results. The restrictions may include refraining from exercise, caffeine, alcohol, smoking, or medication use. During the screening process detailed information will be provided for any study restrictions.
Many of our studies require one or more overnight stays in one of Celerion's clinical facilities. Every participant is assigned a sleeping area at check-in, and in most cases a bunk area is shared with another participant. When sharing a bunk area, roommates are assigned by gender.